Glen Clack

Glen has over 25 years’ experience in oncology drug development and has specialised in the translational medicine aspects of this process. He has successfully provided strategic and operational leadership from Phase I through to regulatory submissions and commercialisation. Glen is an Honorary Professor of Translational Medicine at the University of Sheffield and an MSc Module Tutor and Honorary Lecturer in Translational Science at the University of Manchester. He has an MB BS from the Royal Free Hospital School of Medicine in London, holds an MD from the University of Sheffield and is a Fellow of the Faculty of Pharmaceutical Medicine.